CSR

Building on Our Declaration of Conduct to Deepen Our CSR Initiatives.

CSR

Building on Our Declaration of Conduct to Deepen Our CSR Initiatives.

External Evaluation

  • Dow Jones Sustainability Indices (DJSI)

    Dow Jones Sustainability Indices (DJSI)

    The DJSI are SRI indices developed through collaboration between S&P Dow Jones Indices (U.S.) and RobecoSAM (Switzerland). Sustainability of corporate activity is evaluated on the basis of three dimensions --economic, environmental, and social-- with recognition given to outstanding companies. Sumitomo Dainippon Pharma has continuously satisfied the requirements to become a constituent of the Dow Jones Sustainability Asia/Pacific Index (DJSI Asia/Pacific), the Asia Pacific subset of the Dow Jones Sustainability Indices (DJSI) since 2017.
  • FTSE4Good Index Series

    FTSE4Good

    The FTSE4Good Index Series is created by the global index provider FTSE Russell (U.K.) to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. Sumitomo Dainippon Pharma has been independently assessed according to the FTSE4Good criteria, and has continuously satisfied the requirements to become a constituent of this index since 2003.
  • FTSE Blossom Japan Index

    FTSE Blossom Japan Index

    The FTSE Blossom Japan Index is created by the global index provider FTSE Russell (U.K.) to measure the performance of Japanese companies demonstrating strong Environmental, Social and Governance (ESG) practices. Sumitomo Dainippon Pharma has been independently assessed according to the FTSE Blossom Japan Index criteria, and has satisfied the requirements to become a constituent of this index since 2017.
  • MSCI ESG Leaders Indexes

    MSCI ESG Leaders Indexes

    The MSCI ESG Leaders Indexes is a globally renowned SRI (Socially Responsible Investment) index created by MSCI Inc. of the U.S. Sumitomo Dainippon Pharma has been independently assessed according to the MSCI ESG Leaders Indexes criteria, and has continuously satisfied the requirements to become a constituent of this index since 2010.
  • MSCI Japan ESG Select Leaders Index

    MSCI

    The MSCI Japan ESG Select Leaders Index targets 50% of the free float-adjusted market capitalization of each Global Industry Classification Standard (GICS®) Sector and is designed to target companies that have high Environmental, Social and Governance (ESG) performance. Sumitomo Dainippon Pharma has been independently assessed according to the MSCI Japan ESG Select Leaders Index criteria, and has continuously satisfied the requirements to become a constituent of this index since 2017.
  • SNAM Sustainability Index

    SNAM Sustainability Index

    The SNAM Sustainability index is created by the SOMPO JAPAN Nippon Asset Management (SOMPO JAPAN), and is used in SRI (socially responsible investment) fund for pension funds or institutional investors to invest widely in companies with the high ESG (environment, society, governance) evaluation ratings. Sumitomo Dainippon Pharma has been independently assessed according to the SNAM Sustainability index criteria, and has continuously satisfied the requirements to become a constituent of this index since 2017.
  • SUSTAINA ESG AWARD

    SUSTAINA ESG AWARD is established by SUSTAINA JAPAN in order to celebrate and empower private companies that proactively implement their ESG (Environment, Social, and Governance) management. Based on the original ESG assessment metrics processed by AI, additionally combined with financial evaluation, top 100 ranked companies are selected as ESG Management Leading Companies.
    In FY2018, Sumitomo Dainippon Pharma was selected as one of the ESG Management Leading Companies and received an award of Gold Class in Overall Category as one of the top 20 selected companies. Moreover, we won prizes of Bronze in Governance Category and Gold in Pharmaceutical Industry Category.

    • SUSTAINA ESG AWARD GOLD CLASS
    • SUSTAINA ESG AWARD BRONZE
    • SUSTAINA ESG AWARD GOLD